3i said to consider €1.1bn sale of Havea Group
3i Group is reportedly considering the sale of French natural health products manufacturer Havea Group, which could be valued at approximately €1.1bn.
3i Group
3,729.00p
12:25 21/03/25
Financial Services
17,603.12
12:24 21/03/25
FTSE 100
8,656.61
12:25 21/03/25
FTSE 350
4,725.16
12:25 21/03/25
FTSE All-Share
4,673.58
12:25 21/03/25
Bloomberg cited people familiar with the matter as saying that the private equity firm is speaking with potential advisers to help gauge interest in the business. It was understood that a sale process could start as soon as the first half of next year.
According to Bloomberg, deliberations are in the early stages, and there’s no certainty they will result in a transaction.
Founded in France in 1975, Havea develops, manufactures and distributes natural healthcare and wellness products, including dietary supplements, natural and organic cosmetics. The business was bought by a consortium of 3i and Cathay Capital in 2016.
At 0810 GMT, 3i shares were up 1.3% at 1,418p.